Evidence map›Paper›PMID 41741017›Full record

ArticleThe Journal of international medical research2026

A study on the correlation between DNA methylation and protein expression levels of

Yan Han, Jinling Yang, Hailong Wang, Yuru Xu, Weiqi Wu, Xin Chen, Yifeng Chen

Abstract read
In one paragraph

Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan HanDepartment of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China.ORCID 0009-0006-6453-3609
Jinling YangDepartment of Pathology, Jinjiang Municipal Hospital, China.
Hailong WangDepartment of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China.
Yuru XuDepartment of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China.
Weiqi WuDepartment of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China.
Xin ChenDepartment of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China.
Yifeng ChenDepartment of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PurposeTo investigate the association between Syndecan-2 gene methylation and protein expression dynamics in colorectal cancer and evaluate its clinicopathological significance.MethodsWe analyzed 197 tissues (96 colorectal cancer, 64 adenoma, and 37 normal tissues). Syndecan-2 methylation was quantified using quantitative methylation-specific polymerase chain reaction, and protein expression was evaluated via immunohistochemistry.ResultsSyndecan-2 methylation frequency was significantly higher in colorectal cancer (81.25%) and adenoma (64.06%) than in normal (5.41%) tissues. It showed high diagnostic accuracy for colorectal cancer (area under the curve = 0.88). Although methylation status was unrelated to most clinical parameters, higher methylation levels were correlated with poor tumor differentiation (

Indexed as

AdenomaBiomarkers, TumorColorectal NeoplasmsDNA MethylationSyndecan-2AdultAgedEpigenesis, GeneticFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPromoter Regions, GeneticBiomarkers, TumorSDC2 protein, humanSyndecan-2Colorectal cancerDNA methylationSyndecan-2tumor biomarker

Identifiers

PMID41741017
PMCPMC12946428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.